Subsequently, in order to elucidate the potential mechanism underlying the role of ATM in immunotherapy, we conducted an examination of the association between established immunotherapy biomarkers including tumor mutation burden (TMB), T-cell receptor (TCR), B-cell receptor (BCR), and ATM. This evidence concerns the gene BCR and neoplasm.